Skip to main content

Business

By Jessica Hagen | 12:16 pm | June 12, 2025
Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.
By Jessica Hagen | 04:21 pm | June 11, 2025
The investment will accelerate Nexus IT’s U.S. expansion and support acquisitions of culturally aligned MSPs in healthcare and other regulated industries.
By HIMSS TV | 11:53 am | June 11, 2025
Millie founder and CEO Anu Sharma discusses reasons why one-third of the U.S. is considered a "maternity care desert" and what can be done.  
By Jessica Hagen | 04:17 pm | June 10, 2025
The two organizations will collaborate to accelerate the company's growth and enhance proactive care and management of chronic diseases.
By HIMSS TV | 12:00 pm | June 10, 2025
New chief medical information officers should surround themselves with people who know more than they do and create a team that fills the gap in their knowledge and experience, says Epic Emeritus CMIO Dr. Robert W. Warren.
By Jessica Hagen | 02:06 pm | June 06, 2025
Kidd's company will use 1,000 Bitcoin and additional cash to acquire the interest, and the former Ripple chief risk officer will become CEO and chairman of the board.
By Jessica Hagen | 11:30 am | June 06, 2025
The company is offering 7.9 million of its common stock at an initial price of $19 per share, with shares trading under the ticker symbol OMDA.
HIMSS25
By HIMSS TV | 10:00 am | June 06, 2025
Getting every image, anywhere, to anyone who has the right to the image, including physicians and patients through the personal health record, is a key goal, says Dr. David Kaelber, Cleveland MetroHealth's chief medical informatics officer.
By Jessica Hagen | 12:00 pm | June 05, 2025
Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.
By HIMSS TV | 12:00 pm | June 05, 2025
Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, provides highlights of the venture capital firm's strategy when funding emerging technologies and the risks associated with backing these innovations.